Rising Respiratory Disorders Driving Demand for Oxygen Therapy Equipment

Alma Novak avatar   
Alma Novak
The growing prevalence of respiratory diseases worldwide is a major force accelerating the demand for oxygen therapy equipment. Conditions such as chronic obstructive pulmonary disease (COPD), asthma,..

As these conditions continue to rise due to aging populations, pollution, and lifestyle factors, the oxygen therapy equipment market is experiencing sustained expansion.

The oxygen therapy equipment market is expected to reach US$ 5.6 billion by 2031, registering a CAGR of 6.5% during 2025–2031. This growth reflects the increasing need for reliable oxygen delivery systems across hospitals, homecare settings, and emergency medical services.

COPD remains one of the leading causes of mortality globally and is a major contributor to long-term oxygen therapy demand. Patients suffering from advanced COPD often require continuous oxygen supplementation, creating long-term demand for oxygen concentrators and portable oxygen systems. Similarly, rising asthma cases among children and adults have increased the adoption of oxygen therapy devices in both acute and chronic care settings.

The COVID-19 pandemic further highlighted the importance of oxygen therapy infrastructure. Although the pandemic has subsided, healthcare systems have strengthened oxygen supply chains and invested in long-term respiratory care solutions, which continues to benefit the market. Hospitals and clinics now maintain larger inventories of oxygen therapy equipment to prepare for respiratory emergencies.

Technological advancements have also played a key role in improving treatment outcomes. Modern oxygen concentrators are quieter, more energy-efficient, and easier to operate than earlier models. Portable oxygen concentrators, in particular, are enabling patients to maintain mobility and independence, which significantly improves quality of life.

Leading companies are actively addressing these needs. Koninklijke Philips N.V. offers advanced oxygen therapy systems integrated with respiratory monitoring technologies. Inogen and Invacare Corporation focus heavily on portable and home-based oxygen solutions. Fisher & Paykel Healthcare Limited supports both acute and chronic respiratory care with high-performance oxygen delivery and humidification systems.

In conclusion, the increasing burden of respiratory disorders remains a foundational growth driver for the oxygen therapy equipment market. As awareness and diagnosis rates improve globally, demand for efficient, patient-friendly oxygen therapy solutions will continue to rise through 2031.

Related Reports –

Hyperbaric Oxygen Therapy Devices Market Analysis and Forecast by Size, Share, Growth, Trends 2031

Therapeutic Respiratory Devices Market Key Players Analysis, Opportunities, and Growth Forecast by 2031
Respiratory Care Devices Market Trends and Analysis by 2031

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Information
Website: theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish

 

Комментариев нет